Vibegron
(Redirected from Gemtesa)
What Is Vibegron ?[edit | edit source]
Vibegron (GEMTESA) is a beta-3 adrenergic agonist.
What are the uses of this medicine?[edit | edit source]
- This medication is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
How does this medicine work?[edit | edit source]
- Vibegron is a selective human beta-3 adrenergic receptor agonist.
- Activation of the beta-3 adrenergic receptor increases bladder capacity by relaxing the detrusor smooth muscle during bladder filling.
Who Should Not Use this medicine ?[edit | edit source]
This medicine cannot be used in:
- In patients with known hypersensitivity to vibegron or any components of the product
Is this medicine FDA approved?[edit | edit source]
- It was approved for use in the United States in 2020.
How should this medicine be used?[edit | edit source]
- The recommended dosage of GEMTESA is one 75 mg tablet orally, once daily with or without food.
- Swallow GEMTESA tablets whole with a glass of water.
- In adults, GEMTESA tablets also may be crushed, mixed with a tablespoon (approximately 15 mL) of applesauce and taken immediately with a glass of water.
What are the dosage forms and brand names of this medicine?[edit | edit source]
This medicine is available in fallowing dosage form:
- 75 mg tablets
This medicine is available in fallowing brand namesː GEMTESA
What side effects can this medication cause?[edit | edit source]
Common possible side effects of this medicine include:
- headache
- urinary tract infection
- nasopharyngitis
- diarrhea
- nausea
- upper respiratory tract infection
What special precautions should I follow?[edit | edit source]
- Urinary retention has been reported in patients taking GEMTESA.
- Monitor patients for signs and symptoms of urinary retention.
- Discontinue GEMTESA in patients who develop urinary retention.
What to do in case of emergency/overdose?[edit | edit source]
- There is no experience with inadvertent GEMTESA overdosage.
- In case of suspected overdose, treatment should be symptomatic and supportive.
Can this medicine be used in pregnancy?[edit | edit source]
- There are no available data on GEMTESA use in pregnant women.
Can this medicine be used in children?[edit | edit source]
- The safety and effectiveness of GEMTESA in pediatric patients have not been established.
What should I know about storage and disposal of this medication?[edit | edit source]
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Keep this and all medications out of sight and reach of children.
- Dispose unused medication via a take-back option if available; otherwise follow FDA instructions for disposal in the household trash.
| Vibegron Resources | |
|---|---|
|
 |
| Vibegron Resources | |
|---|---|
|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju
